Cabio Biotech (wuhan) Co. Ltd. Class ASSE: 688089

Announcement on Adjusting the Upper Limit of Phase II Share Repurchase Price after Implementation of Dividend Distribution for 2024

· Issued by Cabio Biotech (wuhan) Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Adjusting the Upper Limit of Phase II Share Repurchase Price after Implementation of Dividend Distribution for 2024

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment